EMA
guidance
· 2014-11-21
CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls
Summary
The CMDh agrees to strengthen warnings on valproate medicines used by women and girls, aiming to reduce risks of birth defects and developmental disorders.
Upgrade for the full analysis, importance score, and drug timeline.